admin – Page 3886 – Get News Story

Lone Wolf Roofing Emerges as Most Trusted Roofing Contractors in Metairie, LA

Lone Wolf Roofing, a popular name in reliable roofing solutions, has once again emerged as the most trusted roofer in Metairie, LA.

Celebrated for its knowledge of fortified roofing systems and its unique designation as a GAF Master Elite Roofer, the organization keeps setting the best benchmarks for client satisfaction, longevity, and quality of work.

Recognized Certifications and Accreditations

Lone Wolf Roofing boasts dual certifications that validate its quality-driven approach:

Fortified Roofer: This certification underscores Lone Wolf Roofing’s commitment to delivering roofing and siding solutions that adhere to rigorous industry standards for weather resistance and durability. From coastal areas prone to hurricanes to locations notorious for severe hail, Lone Wolf Roofing ensures roofs are built to withstand nature’s harshest elements.
GAF Master Elite Roofer: Held by fewer than 2% of roofing contractors worldwide, the GAF Master Elite designation signifies strict yearly training, assessments, and unwavering adherence to top-tier installation and customer service standards. This prestigious certification not only reflects expertise but also grants the ability to offer extended warranties, surpassing the typical coverage available in the market.

Lone Wolf Roofing further reinforces its dedication to excellence through its A+ rating and accreditation from the Better Business Bureau (BBB). The BBB accreditation testifies to the company’s long-standing commitment to transparent and ethical business practices—an integral part of ensuring continuous customer trust and satisfaction.

Comprehensive Achievements and Awards

In addition to its prized industry certifications, Lone Wolf Roofing has amassed a series of accolades and community recognitions, including:

2022-2025 Better Business Bureau (BBB)
2018-2024 Jefferson Parish Recreation Department Coach Volunteer for Youth Growth & Development
2024 Expertise.com Top Roofer of the Year in Metairie, LA
2020-2024 Expertise.com Top 17 Roofers of the Year in Metairie, LA
2020-2024 Volunteers at Second Harvest Food Bank
2020-2024 Quality Business Award Nominee
2023-2024 Outstanding Workmanship Award via the National Roofing Contractor Association
2022 Louisiana Contractor’s Association Certificate for Roofing Excellence
2020-2025 GAF Master Elite Residential Roofing Contractor
2023-2025 IBHS Fortified Certified Roofing Contractor (Hurricane, Hail, & Wind)
2023 ENR Top 20 Under 40
2022-2024 Top 100 Contractors in the USA (RoofingContractor.com)
2021-2024 Malarkey Roofing Shingles Installment Certification
2021-2024 IKO Preferred Roofer

These distinctions highlight Lone Wolf Roofing’s broad commitment to industry leadership, community service, and continuous professional development. From volunteer coaching at the Jefferson Parish Recreation Department to helping at Second Harvest Food Bank, the company’s ethos of giving back to the community goes well beyond the rooftops they secure.

A Message from Lone Wolf Roofing

“By selecting Lone Wolf Roofing, you’re not merely engaging a contractor but collaborating with certified specialists who focus on strengthening your property’s safety and durability,” said Clare Manale, Owner of Lone Wolf Roofing. “Whether enhancing to a fortified roof for increased weather defense or pursuing the long-term advantages of GAF Master Elite roofing, Lone Wolf Roofing guarantees every investment is valuable.”

Benefits of Working with Lone Wolf Roofing

Trusted Expertise: As both a Fortified Roofer and a GAF Master Elite Roofer, Lone Wolf Roofing provides certified skill and proven experience.
Extended Warranties: Thanks to its GAF Master Elite status, the company offers extended warranties that go beyond typical coverage, providing lasting peace of mind.
High-Quality Materials and Methods: Each roof is constructed using the latest, most durable materials and techniques, ensuring optimal longevity and performance.
Customer-Focused Service: The team prioritizes client satisfaction from the first consultation to the final installation, tailoring each project to specific needs.
Professional Advice: Experienced staff guide clients through the advantages of fortified and GAF Master Elite roofing, enabling informed decisions.
Effortless Setup: Lone Wolf Roofing manages all aspects of each project, from initial planning to final execution, with expertise and meticulous attention to detail.
Thorough Assistance: Whether responding to inquiries, addressing concerns, or helping clients understand extended warranties, the company’s commitment to excellence underpins every interaction.

Learn More and Contact Information

To discover more about Lone Wolf Roofing and its range of roofing services, visit:

https://lonewolfroofs.com/

To learn more about the best roofing services in Metairie, Louisiana, contact Lone Wolf Roofing at 504-230-6512 or book a free consultation.

About Lone Wolf Roofing

Lone Wolf Roofing specializes in providing premium roofing solutions satisfying strict Fortified and GAF Master Elite criteria. Emerging as the most reliable roofing contractor in Metairie, LA, the company is committed always to durability, professional knowledge, and customer happiness. From ethical service to weather-resistant installations, Lone Wolf Roofing emphasizes safeguarding and improving the value of every client’s property.

For updates, follow Lone Wolf Roofing on social media: https://linktr.ee/lonewolfroofing

Media Contact
Company Name: Lone Wolf Roofing
Contact Person: Clare Manale, Owner
Email: Send Email
Phone: 504-230-6512
City: Metairie
State: Louisiana
Country: United States
Website: www.lonewolfroofs.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lone Wolf Roofing Emerges as Most Trusted Roofing Contractors in Metairie, LA

Lone Wolf Roofing becomes the Top Roofing Contractor in Metairie, LA

With great pride, Lone Wolf Roofing is proud to announce that it is formally the top roofing contractor in Metairie, Louisiana. Acknowledged for providing premium, dependable roofing solutions, Lone Wolf Roofing has established itself as the top rated roofing contractor in Metairie, Louisiana.

Industry-Leading Certifications and Expertise

The ascent of Lone Wolf Roofing is not random. Two of the most esteemed certificates in the roofing business belong to the company.

A Master Elite Roofer from GAF is a special accreditation that 2% or less of roofing contractors in the country have, which guarantees Lone Wolf Roofing satisfies the highest criteria in quality installation, customer satisfaction, and extended warranty choices. Lone Wolf Roofing offers industry-best warranties as a GAF Master Elite contractor, therefore providing long-term peace of mind.

Expert in hurricane, hail, and wind-resistant roofing, IBHS Fortified Certified Roofing Contractor Lone Wolf Roofing is a reliable name for homeowners trying to guard their investments against severe weather. This certification guarantees that every roof is constructed using the most modern materials and methods, offering improved resistance against natural calamities.

A+ Accredited Better Business Bureau (BBB) With a Better Business Bureau A+ rating, Lone Wolf Roofing is proof positive of its dedication to openness, moral business ethics, and first-rate customer service.

Why is Lone Wolf Roofing the First Choice for Metairie?

Enhanced Roofing Solutions: Lone Wolf Roofing delivers the best degrees of knowledge to every project with Fortified and GAF Master Elite certifications.

Extended Warranties: The company offers warranties exceeding industry standards as a GAF Master Elite Roower, so offering years of peace of mind.

Creating a Point of Difference

Understanding that every property is different, the Lone Wolf Roofing crew makes sure every roofing solution is catered to a customer’s particular requirements.

From the first evaluation to the last walkthrough, Lone Wolf Roofing offers open communication and comprehensive direction from a customer-centric standpoint.

Lone Wolf Roofing addresses each stage of roofing—from inspection to completion—allowing for minimum delays and on-time project delivery by means of a simplified methodology.

Focusing on Fortified roofing systems, Lone Wolf Roofing creates buildings meant to survive the extreme climatic conditions of the area, including hurricanes, hail, and strong winds.

“Every roof we build is evidence of our relentless quality commitment,” said Manale. “Our customers know they can rely on us for roofing that not only looks fantastic but also stands strong when severe weather strikes.”

For homeowners and businesses looking to upgrade their roofs with the most trusted contractor in Metairie, Lone Wolf Roofing offers free consultations to assess roofing needs and provide expert guidance.

To learn more about the best roofing services in Metairie, Louisiana, contact Lone Wolf Roofing at 504-230-6512 or book a free consultation.

About Lone Wolf Roofing

Lone Wolf Roofing specializes in providing high-quality, long-lasting roofing solutions that meet the industry’s most rigorous standards, including GAF Master Elite and IBHS Fortified Roofing Certification. Recognized for excellence in craftsmanship, customer service, and community involvement, Lone Wolf Roofing continues to be Metairie’s most trusted roofing company.

To learn more, visit https://lonewolfroofs.com/.

For updates, follow Lone Wolf Roofing on social media: https://linktr.ee/lonewolfroofing

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lone Wolf Roofing becomes the Top Roofing Contractor in Metairie, LA

Joint Replacement Devices Market to Hit USD 31.09 Billion by 2030 with 4.8% CAGR

“prominent players in the joint replacement devices market are Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).”

Browse 333 market data Tables and 63 Figures spread through 375 Pages and in-depth TOC on “Joint Replacement Devices Market by Product (Knee, Hip, Shoulder, Ankle, Elbow, Wrist, Bone Grafts), Surgery (Total, Partial, Revision), Type(Cemented, Cementless, Hybrid), Procedure type, End user (Hospitals, ASC, Trauma, Clinic) – Global Forecast to 2030

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 billion in 2024 and an impressive US$31.09 billion by 2030. The main factor driving this market is the increasing rate of orthopaedic disorders, especially among the baby boomer population. Additionally, the market is growing due to various initiatives by major companies, including the introduction of new joint replacement devices. The rising demand for joint replacement devices is further supported by the growing number of hospitals and surgical centers and improved healthcare access in developing countries. The key players in this market focus on expanding their reach in emerging economies by applying various strategies such as collaborations and agreements, further driving market growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=178584762

Browse in-depth TOC on “Joint Replacement Devices Market“

333 – Tables

63 – Figures

375 – Pages

The joint replacement devices market is segmented based on product into knee replacement devices, hip replacement devices, shoulder replacement devices, elbow replacement devices, ankle implants, wrist replacement devices, other replacement devices, and bone graft substitutes. The knee replacement devices segment is expected to hold major share of the market in 2023. The increase in number of knee replacement procedures and the increasing incidence of knee osteoarthritis is driving the growth of this segment. Each year more than 70,000 knee replacement procedures are performed in England and wales each year (Source: NHS). In the year 2022, the revision and primary knee and hip arthroplasty procedures performed were 3,149,042 from 2012 to 2022 i.e., 23% growth in procedural cases (Source: American Academy of Orthopaedic Surgeons).

By surgery type, the joint replacement devices market is segmented into total replacement, partial replacement, and revision replacement. In 2023, the total replacement segment held a significant share of the market 2023. The growth in this segment is driven by the increasing number joint replacement surgeries such as hip and knee replacement and increasing incidence of osteoarthritis. In case of total replacement, the damaged cartilage along with the bone is replaced with an artificial implant that mimics the shape of the natural joint and help individual to carry out the day-to-day activities.

By type, the joint replacement devices market is segmented into cemented fixation, cementless fixation, reverse hybrid fixation, and hybrid fixation. In the year 2023, the cemented fixation segment held largest share of the market. There are multiple factors attributing to the largest share of the segment such as enhanced bone fixation, improved stability of an implant in patient’s body, and enhanced assistance drives the growth of the segment. Cemented fixation also enables the delivery of antibiotics at the targeted site, helps to reduce thigh pain, and enhances the survival of an implant.

By technique, the joint replacement devices market is segmented into traditional surgery, minimally invasive surgery and computer assisted surgery. In 2023, the minimally invasive surgery held largest share in the global joint replacement devices market by technique. The factors contributing to its largest share are need for smaller incision, reduced pain, and increased awareness among individuals for early detection.

Regarding end users, the joint replacement devices market is fragmented into hospitals & surgical centers and ambulatory care centers & trauma units, and orthopedic clinics. The major share of the market was contributed by hospitals & surgical centers segment in 2023. Consistent rise in new funding opportunities and increasing focus on research specifically in healthcare by various public and private organizations are fueling the segment growth. Furthermore, increasing number of hospitals and advanced surgical centers which are equipped with new and innovative surgical equipment support the growth of the segment.

The joint replacement devices market is segmented by region into Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2023, North America region accounted for the major market share, followed by Europe and Asia Pacific. The significant share of North America in this market is attributed to the existence of major key players, change in lifestyle, increasing geriatric population, and rising prevalence of bone disorders. Furthermore, factors such as increasing healthcare expenditure and growing number of various joint replacement treatments due to increase in awareness among common people coupled with early detection supports the market growth in this region.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=178584762

The joint replacement devices market is consolidated. As of 2023, the key players operating in the global joint replacement devices market are Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B.Braun (Germany). In 2023, Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US) held a significant share of the joint replacement devices market. These players have adopted key strategies such as acquisitions, partnerships, and expansions in the last four to five years that contributed to their position in the joint replacement devices market.

Stryker Corporation (US)

Stryker Corporation is among the leading companies in the global joint replacement devices market. The organization has a robust presence in the global market including regions like Europe, North America, the Middle East, Africa, and the Asia Pacific. The company its brand presence in more than 75 countries across the global market. The company provides joint replacement devices through its Orthopaedics & Spine division business segment. The company focuses on improving its product portfolio and making new additions to the same. It focuses on innovation and offers unique products to sustain its leading position in the market. The company also focuses on R&D and bring technologically advanced products in the market for its customers addressing their unmet needs.

Zimmer Biomet Holdings, Inc. (US)

Zimmer Biomet is one of the leading companies in the joint replacement devices market. It is involved in the manufacturing and marketing of a range of medical devices and related products in healthcare industry. The company offers joint replacement devices through its Knees, Hips, and S.E.T segments. The company holds a robust presence across multiple countries such as Germany, France, Italy, Switzerland, Spain, the UK, Japan, South Korea, China, Australia, New Zealand, Taiwan, India, Hong Kong, Thailand, Singapore, and Malaysia. Also, the company distributes its products across Central & Eastern Europe, Benelux, Nordic, and the Middle East & Africa. Zimmer Biomet maintains a strong product portfolio, has a robust brand value among joint replacement devices end users, and strong R&D capabilities.

Johnson & Johnson MedTech (US)

Johnson & Johnson MedTech is another major player operating in the joint replacement devices market. The company is involved in the manufacturing, R&D, and marketing of joint replacement devices and other healthcare products globally. It offers joint replacement devices under the MedTech business unit. The company is dedicated to offering technologically advanced products focused on enhancing clinical outcomes. The company made a collaboration with CrossRoads Extremity Systems (US) with an aim to improve orthopaedic care with new and innovative ideas, hoping to give patients enhanced health results. The company holds a remarkable market share in more than 60 countries across diverse territories such as Asia Pacific, North America, Middle East & Africa, and Europe.

For more information, Inquire Now!

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/joint-replacement-market-178584762.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Joint Replacement Devices Market to Hit USD 31.09 Billion by 2030 with 4.8% CAGR

EarFun Launches Wave Life ANC Headphones with Hi-Res Audio, Bluetooth 5.4 & 60-Hour Battery Life for only $60

“The Best Budget Hybrid ANC Over-ear Wireless Headphones”

EarFun is excited to introduce the Wave Life, its latest hybrid active noise-canceling headphones, priced at just $59.99. These all-new over-ear headphones are designed to redefine audio quality and features under $100, offering a premium experience for budget-conscious listeners without compromising on performance.

Key Features

• Powerful Hybrid Noise Cancellation performance eliminates noise up to 45dB

• Hi-Res Audio certified with 40mm Composite Drivers with Customizable EQ*

• 60 Hours of Efficient Battery Life from a Single Charge and USB Audio

EarFun, the innovative consumer audio brand, is releasing its newest hybrid active noise-canceling headphones named the Wave Life, a budget-conscious, all-new over-ear headphone. Priced at $59.99, the Wave Life aims to redefine what sound, features, and quality can be attained for well below the sub $100 price range. The new hybrid ANC headphones will retain much of the feature-rich offering of the current award-winning Wave Pro while making it more accessible to the budget-minded who still care about having a premium audio experience.

With Hi-Res Audio, Hybrid Active Noise Cancelation (ANC) up to 45dB, Bluetooth 5.4, and 60 hours of battery life, the Wave Life offers everything to make it a daily companion. The Wave Life provides a robust feature set and configurations accessible through EarFun’s Audio App, which offers thoughtful music, streaming, and interface customization for true versatility.

Bluetooth 5.4 and 60 Hours of Wireless Freedom

Wireless connections are the fastest yet with the EarFun Wave Life, as pairing with compatible Bluetooth devices is instantaneous, super secure, and has an increased range. The Wave Life comes with the latest wireless connectivity, Bluetooth 5.4. As a result, playback time can reach up to 60 hours on a single charge using the USB-C rechargeable case. It also supports fast charging, bringing you back online within minutes.

True ANC Immersion and True-to-Life Hi-Res Sound

Hi-Res Audio certified, the Wave Life offers a wide, natural frequency range that gives definition and detail to music and media. Deep, rich bass, well-defined mids, and a beautiful, engrossing treble at the top end make for a premium audio experience. Powering the Wave Life are two handsome 40 mm Composite Drivers that produce the dynamic and lively EarFun sound signature.

Talk, Listen, and Escape with 4 AI-powered Microphones

The Wave Life offers a true escape by integrating an intelligent AI that works continuously to filter out ambient background sounds and chatter that can be disruptive. The Advanced Hybrid Active Noise Cancellation (ANC) eliminates up to 45dB, inducing library-level quiet for total immersion.

An incisive algorithm guides the integrated 4-Mic system to not only mitigate the sound around you but also distill your voice and make it clear for the other person during a phone call or an online meeting.

Sound, Settings, and Ergonomics Just for You

Personalizing the sound of the Wave Life is a breeze. Accessing EarFun’s Audio App allows you to take advantage of the customizable EQ that best compliments the genre of music. The all-in-one app can adjust ANC mode and other interface settings. The Wave Life also offers Multipoint Connection to allow simultaneous connection of two Bluetooth-enabled devices with the ability to toggle between devices.

When work is over, the Wave Life is ready for playtime. The dedicated Game Mode in the EarFun Audio App delivers ultra-low latency times ideal for competitive gaming, where response time and synchronicity matter. This setting is also perfect for movies and series streaming, keeping sound effects and explosions in sync. Gaming makes time pass quickly, so the Wave Life can be plugged in via USB for a direct audio connection to your PC when the battery runs low. And thankfully, the Wave Life is built for all-day wear. With a lightweight design and a breathable fit, the comfort-focused design of the Wave Life ensures fatigue doesn’t ensue from extended usage.

Pricing & Availability

The EarFun Wave Life will go on sale on 10th March on EarFun’s official website and Amazon official store at $59.99.

For more information on EarFun Wave Life and the rest of the EarFun wireless audio collection, visit www.myearfun.com.

About EarFun

EarFun, an audio brand established in California in 2018, is run by an experienced group of industrial designers, acoustic engineers and music enthusiasts who share the goal of creating next-generation wireless audio devices. The EarFun team is driven by a passion for music and a commitment to delivering solutions that use the latest technology to improve sound for wireless audio products. EarFun has become one of the most acclaimed wireless audio brands worldwide within just 3 years.

EarFun PR Contacts:

For Images / Sample Requests

Helen Shaw

media@myearfun.com

Media Contact
Company Name: EARFUN, INC.
Contact Person: Helen
Email: Send Email
Phone: 1-772-245-0820
Country: United States
Website: www.myearfun.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: EarFun Launches Wave Life ANC Headphones with Hi-Res Audio, Bluetooth 5.4 & 60-Hour Battery Life for only $60

Temperature Monitoring Systems Market to Hit USD 5.66 Billion by 2030 with 5.3% CAGR

“prominent players in temperature monitoring systems are 3M (US), Cardinal Health (US), Emerson Electric (US), Honeywell International Inc. (US), Koninklijke Philips N.V. (Netherlands), ABB (US), Fortive Corporation (US)”

Browse 437 market data Tables and 64 Figures spread through 417 Pages and in-depth TOC on “Temperature Monitoring Systems Market by Type (Wireless, Strip, Pyrometer, IR), Application (Patient Monitoring, Lab, Manufacturing, Cold Storage, Home Care, Server), End User (Healthcare, Food, Pharma, Energy, Semi-conductor) – Global Forecast to 2030

The temperature monitoring systems market valued at US$ 3.80 Billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$ 4.15 Billion in 2024 and an impressive US$ 5.66 Billion by 2030. During the forecast years, the growth of the market is attributed to the focus on advancements in temperature monitoring systems technology, growing patient population, increasing initiatives to promote temperature monitoring systems awareness. Increasing use of temperature monitoring for cold storage among market players are also expected to support the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250125379

Browse in-depth TOC on ‘Temperature Monitoring Systems Market’

437 – Tables

64 – Figures

417 – Pages

Moreover, in recent years, the market players are also focusing on providing cost-effective temperature monitoring systems due to its growing demand amongst various end users in the market. Also, there is an increasing demand for temperature monitoring systems specially for cold storage monitoring in the emerging markets. All these factors are expected to drive provide growth opportunities for market players offering temperature monitoring systems.

Temperature monitoring systems are gaining recognition due to increasing awareness, technological advancements, regulatory requirements, demand for IoT integrated sensor and AI technologies. Also, governments in these countries are prioritizing the provision of modern & advanced healthcare services to larger portion of their population. Factors such as improved reimbursement coverage, rapid growth in per-capita healthcare expenditure and increasing public demand for affordable healthcare services are driving the expansion of healthcare products, including patient monitoring systems. This trend is reflected in the overall rise in healthcare expenditure. For example, the World Bank projects global healthcare spending to increase by 5-6% annually through 2030, driven by rising demand for surgical procedures and aging populations. Furthermore, healthcare spending in emerging markets, such as Brazil, India, and South Africa, is expected to grow by over 7% annually, as governments and private sectors prioritize health investments.

In addition to expansion in the secondary manufacturing sector, the markets in developing countries are characterized by the presence of stringent regulatory policies for food and drug safety. Also, growth of the biotechnology and pharmaceutical industries in the Asia Pacific are considered to be more adaptive and business-friendly by market players. All these factors are encouraging market players to focus more on emerging markets in the coming years.

The significant target patient population, untapped opportunities in energy and power industry, and low competition in developing economies such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the temperature monitoring systems market.

Based on the product, temperature monitoring systems market is segmented into monitoring systems and software & service. The monitoring system segment is further divided into analog and digital monitoring systems. Whereas the software & service segment is segmented into data management and monitoring solutions, predictive analytics, maintenance & calibration services and other software & services. During the forecast period, monitoring systems is expected to dominate the temperature monitoring systems market. The growing need for cold chain logistics for vaccine storage is one of the major factors after the growing number of cancer cases for the adoption of the system. Furthermore, the growth of the system segment will be driven by increasing healthcare infrastructure in developing countries.

Based on type, the temperature monitoring systems market is segmented into contact-based and non-contact-based temperature monitoring systems. The contact-based temperature monitoring systems is further divided into conventional temperature monitoring systems, temperature measuring strips and labels, and wireless temperature monitoring systems. Meanwhile, the non-contact-based temperature monitoring systems is further divided into pyrometers and infrared thermometers, thermal imagers, and fiber optic thermometers. Throughout the forecast period, the contact-based temperature monitoring systems segment is projected to claim the leading position in the market. The primary growth drivers include the demand for continuous temperature monitoring and the increased precision & accuracy of temperature monitoring.

Based on application, the temperature monitoring systems market is segmented into hospital room and patient temperature monitoring, manufacturing area temperature monitoring, cold storage temperature monitoring, laboratory temperature monitoring, server room temperature monitoring, greenhouse temperature monitoring and home care temperature monitoring. During the forecast period, the cold storage monitoring sector is poised to command the most substantial market share in the temperature monitoring systems market. This dominance is fueled by the increasing adoption and the efficacy of temperature monitoring of cold storage for vaccine, drugs & food products storage and supply.

The temperature monitoring systems market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East. In 2024, the Asia-Pacific region is anticipated to present noteworthy growth prospects for temperature monitoring systems. This expansion is credited to the rising healthcare spending, the growth of the chemical, petrochemical, energy and power generation company sectors in India and China, and annual rise in geriatric population in several Asia Pacific countries.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=250125379

The temperature monitoring systems market exhibits moderate competitiveness, featuring both established companies and emerging competitors for the same market share. As of 2023, the key player operating in the global temperature monitoring systems market are 3M (US), ABB Ltd. (Switzerland), Cardinal Health (US), Emerson Electric (US), Honeywell International Inc. (US), Koninklijke Philips N.V. (Netherlands), Welch Allyn (US) and Vaisala (Finland).

In the past four years, top players in this market have employed key strategies such as product launches, making agreements, and undertaking expansions. In 2023, a major share of the temperature monitoring systems market was held by 3M (US), Cardinal Health (US), Emerson Electric (US), Honeywell International Inc. (US) and Koninklijke Philips N.V. (Netherlands).

3M (US)

3M held the leading position in the market, with the most significant global share in 2023. The company offers a broad product portfolio to gain the leading market share, including diagnosable thermometers and wireless and digital products. The company focuses on organic and inorganic growth strategies to enhance its footprint. 3M has a strong brand recall and global network. The company adheres to regulatory compliance for key end-use customers. The company focuses on sustainability.

ELEKTA (SWEDEN)

Honeywell sells its products and services through direct sales and third-party distributors and has a strong presence in North America, the Asia Pacific, and Europe. The growth in the company’s sales, which was particularly strong in North America, Europe, and Asia, helped maintain its leading position. Honeywell offers advanced sensor technologies for temperature monitoring. The company has a strong presence in cold chain management among the various applications of temperature monitoring products.

ACCURAY INCORPORATED (US)

Emerson Electric is a global innovation company providing commercial and residential automation solutions. The company focuses on innovation in temperature monitoring systems to provide advanced solutions. It is a leading temperature monitoring systems industry player with a strong market presence in over 50 countries. Emerson Electric primarily pursues product innovation to sustain its position in the global market.

For more information, Inquire Now!

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Temperature Monitoring Systems Market to Hit USD 5.66 Billion by 2030 with 5.3% CAGR

Anti-snoring Devices Market worth $1.45 billion by 2029

“The major market players involved in this market are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US)”

Browse 381 market data Tables and 48 Figures spread through 279 Pages and in-depth TOC on “Anti-snoring Devices Market by Device Type (Oral Appliances, Nasal Devices, Position Control Devices), Gender (Male, Female), Age (Between 40-60, above 60), Distribution Channel (Online, Retail), End User (Homecare, Hospital) – Global Forecast to 2029

The global anti-snoring devices market, valued at US$ 0.83 billion in 2023, is forecasted to grow at a robust CAGR of 9.8%, reaching US$ 0.91 billion in 2024 and an impressive US$ 1.45 billion by 2029.

The anti-snoring devices market is expected to grow due to factors such as the increasing prevalence of sleep disorders like sleep apnea; advancements in sleep therapy technologies; and the expanding aging population with the subsequent increase in chronic conditions. Additionally, the increasing rates of obesity along with the growing consumption of alcohol & cigarettes among people are other factors expected to contribute to market growth. Moreover, innovations in oral appliance technology and enhanced features for regularized patient compliance are expected to provide significant opportunities for market growth during the forecast period by improving patient compliance and encouraging adoption.

The fastest-growing device segment is the oral appliances segment, which includes mandibular advancement devices (MADs) and tongue-retaining/stabilizing devices (TRDs). The large share of the oral appliances segment can be attributed to the growing awareness among healthcare providers & patients regarding the cost-efficiency and easy availability of oral appliances. Additionally, government initiatives promoting awareness about snoring and untreated sleep apnea are expected to improve diagnosis rates and boost the demand for anti-snoring devices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215567849

Browse in-depth TOC on ‘Anti-snoring Devices Market’

381 – Tables

48 – Figures

279 – Pages

Based on device type, the anti-snoring devices market is divided into oral appliances, nasal devices, position control devices, chin straps, and EPAP therapy devices. In 2023, the oral appliances segment accounted for the largest share of the anti-snoring devices market. The large share of this segment can be attributed to the popularity of MADs, backed by extensive research supporting their effectiveness over other devices.

Based on Gender, the anti-snoring devices market is segmented into male and female. The male patients segment accounted for the largest share of the anti-snoring devices market in 2023. Factors supporting the growth of this market segment include differences in the structure and physiological behavior of the upper airway, in the craniofacial morphology, and in the pattern of fat deposition in males and females. This factor is expected to lead to a higher risk of OSA and snoring in males, thus fueling market growth.

Categorized by distribution channels, the anti-snoring devices market is segmented into online pharmacies, retail pharmacies, and hospital pharmacies & dental clinics. Retail pharmacies accounted for the largest share of the anti-snoring devices market in 2023. Factors supporting the growth of this segment include the convenience, affordability, and accessibility of these distribution channels.

Based on end users, the anti-snoring devices market is segmented into home care settings and hospitals & clinics. The home care settings segment accounted for the largest share of the anti-snoring devices market in 2023. The large share of this segment can be attributed to the increasing patient preference for home sleep testing and the growing number of advanced home sleep care devices available in the market.

The anti-snoring devices market is segmented into six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries. North America dominates the global market and is expected to continue during the forecast period. The rising prevalence of sleep apnea and snoring in the population and the growing demand for alternative treatment options due to poor compliance associated with CPAP are expected to drive market growth in the region. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The high growth rate of the Asia Pacific market can be attributed to the large undiagnosed population; the rising incidence of chronic diseases; growing awareness of sleep testing; and improved healthcare infrastructure for adopting technologically advanced sleep therapy devices.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=215567849

The major market players involved in this market are ResMed (US), SomnoMed (Australia), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US), DynaFlex (US), OpenAirway (Canada), Panthera Dental (Canada), Airway Management (US), Apnea Sciences (US), OravanOSA (US), Myerson LLC. (US), Braebon Medical Corporation (Canada), MPowrx Health and Wellness Products (Canada), The Snore Reliever Company, LLC (US), Tomed GmbH (Germany), The Aurum Group (Canada), OSCIMED SA (Switzerland), SICAT GmbH & Co. KG (Germany), Glidewell (US), ApnoMed, Inc. (US), ZQuiet (US), Dream Systems Dental Sleep Lab (US), The Snore Reliever Company, LLC (US), The Pure Sleep Company (US), Tomed GmbH (Germany), THE AURUM GROUPS (Canada), Innovative Health Technologies (New Zealand), and Theravent, Inc. (US) among others.

F. HOFFMANN-LA ROCHE LTD.

In 2023, ResMed (US) generated approximately USD 4.1 billion in revenue from its Sleep and Respiratory Care business segment, which includes anti-snoring devices. In contrast, Vivo Therapeutics, Inc. (US) experienced a decline in revenue due to several challenges. These challenges included escalating inflation, increasing raw material costs and necessitating price adjustments, potentially reducing consumer demand. Additionally, global supply chain disruptions and geopolitical tensions have heightened economic uncertainty. Furthermore, higher interest rates have added to financial strain, impacting demand and capital acquisition.

SomnoMed (Australia)

The company had the second-largest market share, accounting for 4.3% in 2023. SomnoMed has a strong presence in North America and Europe and aims to expand further into emerging markets like the Asia Pacific. The company boasts a robust product portfolio, with FDA- and CE Mark-approved products that have helped it maintain its market presence. SomnoMed has been leading in technological advancements and frequently introduces new products such as SomnoDent Herbst, SomnoDent Fusion, SomnoDent Herbst Advance, and SomnoDent with Compliance Recorder. Additionally, the company has launched SomnoDent Herbst Advance Elite, a PDAC-verified milled oral appliance designed to treat mild-to-moderate obstructive sleep apnea.

ProSomnus Sleep Technologies (US)

ProSomnus Sleep Technologies is another major player in the anti-snoring devices market. The company specializes in producing and selling precise intraoral medical devices that provide non-invasive mild-to-moderate obstructive sleep apnea treatment. ProSomnus Sleep Technologies develops its products using a proprietary, highly automated, and scalable manufacturing process. The company ranked as the third largest in the anti-snoring and sleep apnea devices market, with a growing market share in 2023. ProSomnus has a significant presence in North America and is expanding its reach into other regions, including Europe and Asia. The company offers a diverse portfolio of FDA-cleared and CE-marked oral appliances, designed for personalized and effective treatment of snoring and obstructive sleep apnea (OSA). The company is also dedicated to providing clinical evidence supporting its products’ efficacy, positioning it as a trusted name among sleep specialists and healthcare providers.

For more information, Inquire Now!

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Anti-snoring Devices Market worth $1.45 billion by 2029

Vietnam Crawler Excavator Market to Reach 1,974 Units in Sales by 2029, Generating $94.5 Million in Revenue Over the Next 6 Years – Arizton

“Vietnam Crawler Excavator Market Research Report by Arizton”

According to Arizton’s latest research report, the Vietnam crawler excavator market is growing at a CAGR of 4.41% during 2023-2029.

Curious to Know More About the Market? Click:https://www.arizton.com/market-reports/vietnam-crawler-excavator-market-opportunities-assessment-forecast

Report Scope      

Market Size – Volume (2029): 1,974 Units      

Market Size – Volume (2023): 1,524 Units     

CAGR – Volume (2023-2029): 4.41%  

Market Size – Revenue (2029): USD 94.5 Million   

Historic Year: 2020-2022     

Base Year: 2023     

Forecast Year: 2024-2029     

Market Segmentation: Size, Gross Power, and End Users

Market Trends

Labor Shortage in Vietnam Drives Demand for Excavators with Automation & Smart Technology

In 2023, Vietnam faced a severe labor shortage in key industries like construction, manufacturing, and mining, primarily due to a decline in migrant workers from countries like Indonesia, Thailand, and Bangladesh. This shortage spurred the demand for advanced technologies in construction equipment to improve worker efficiency and reduce reliance on manual labor. In response, companies like Hitachi introduced excavators and wheel loaders with automation and smart operation technology, including the Consite Hitachi Comprehensive Machine Management system. Other major manufacturers, such as Komatsu, Liugong, and Volvo, also followed suit by incorporating innovative solutions to address labor challenges.

Vietnam’s Infrastructure Investment Boosts Demand for Crawler Excavators

In 2024, the Vietnamese government announced plans to invest over $25 billion in public infrastructure projects, with nearly 65% allocated to the transport sector. This investment aims to improve transit efficiency and create new development opportunities across the country. The government is relying on domestic, foreign, and private investment channels, focusing on transport to reduce logistics costs and enhance economic competitiveness. Key projects include 34 major infrastructure developments and 11 expressway constructions, including projects in Hanoi and Ho Chi Minh City. The planned investments, totaling $480 billion by 2030, are expected to drive significant demand for crawler excavators to support these infrastructure projects.

Mini Excavator Market in Vietnam: A Growing Sector

The mini excavator market in Vietnam is projected to reach $11.0 million by 2029. Mini excavators are widely used for construction, demolition, earthmoving, and landscaping tasks due to their operational versatility and compatibility with various attachments. In 2024, Vietnam experienced a significant surge in foreign direct investment (FDI) in its construction sector, with FDI inflows expected to rise by 32%. Ongoing infrastructure development projects in major cities like Ho Chi Minh, Ha Noi, and Hai Phong are driving the demand for mini excavators. The market is set to grow due to increased construction, landscaping needs, and technological advancements.

Key Players in the Vietnam Crawler Excavator Market

Market Leaders: Caterpillar, Kobelco, SANY, Hitachi Construction Machinery, and Komatsu dominate the Vietnam crawler excavator market. These industry giants hold a strong market share and offer a broad range of equipment.

Niche Players: Kubota, Liu Gong, Yanmar, JCB, Airman, and Bobcat focus on the local Vietnamese market. These companies offer limited product diversification and cater to specific customer segments.

Emerging Competitors: Volvo Construction Equipment, SDLG, Zoomlion, Yuchai, John Deere, Hyundai Construction Equipment, and XCMG are gaining traction in the Vietnam crawler excavator market. These players are introducing innovative, advanced products to challenge established market leaders.

Stragglers: Sumitomo, Shantui, Wacker Neuson, and Develon are lagging behind in the Vietnam crawler excavator market. These companies are typically behind on product innovation and technological advancements compared to their competitors.

France Crawler Excavator Market Dynamics

Drivers

Investment in Infrastructure Projects
Rising Investment in Transport Industry
Surge in Investment in Renewable Energy Sector

Trends

Shortage of Labor Triggers Demand for Excavators Equipped with Automation & Smart Operation Technology
Rising Focus on Compact and Electric Construction Equipment
Introduction of Dual Excavator in the Vietnamese Market Due to Its Flexible Uses

Challenges

Poor Performance of Real Estate Industry
Vietnam Currency Depreciation Impacts Imports
Continuous Increase in Building Material Prices Hampered Construction Projects

Buy this Research Now @ https://www.arizton.com/market-reports/vietnam-crawler-excavator-market-opportunities-assessment-forecast

Major Vendors

Caterpillar
Komatsu
Volvo Construction Equipment
Hitachi Construction Machinery
Kubota
SANY
JCB
Xuzhou Construction Machinery Group (XCMG)
Kobelco
Zoomlion Heavy Industry Science & Technology Co., Ltd.
Hyundai Construction Equipment
Liugong
Yanmar
SUMITOMO CONSTRUCTION MACHINERY CO., LTD.
Takeuchi
Bobcat
AIRMAN
Shandong Lingong Construction Machinery
Develon

Distributor Profiles

CONSTRUCTION MACHINERY HOANG GIA
BinhLoi CO.,LTD
T&C Machinery & Parts JSC

Market Segmentation

Crawler Excavator

Size

Mini Excavator
Small Excavator
Medium Excavator
Large Excavator

Gross Power

Less Than 60 HP
60 HP -100 HP
101 HP-200 HP
Above 200 HP

End Users

Construction
Mining
Agriculture
Forestry
Others (Power Generation, Utilities Municipal Corporations, Oil & Gas, Cargo Handling, Power Generation Plants, Waste Management)

Key Questions Answered in the Report:     

How big is the Vietnam crawler excavator market?

What is the growth rate of the Vietnam crawler excavator market?

Who are the key players in the Vietnam crawler excavator market?

Which are the major distributor companies in the Vietnam crawler excavator market?

What are the trends in the Vietnam crawler excavator industry?

Check Out Some of the Top Selling Research Reports:     

Japan Crawler Excavator Market – Strategic Assessment & Forecast 2024-2029

https://www.arizton.com/market-reports/japan-crawler-excavator-market-opportunities-assessment-forecast

Indonesia Crawler Excavator Market – Strategic Assessment & Forecast 2024-2029

https://www.arizton.com/market-reports/indonesia-crawler-excavator-market-opportunities-assessment-forecast

Why Arizton?                                     

100% Customer Satisfaction                                     

24×7 availability – we are always there when you need us                                     

200+ Fortune 500 Companies trust Arizton’s report                                     

80% of our reports are exclusive and first in the industry                                     

100% more data and analysis                                     

1500+ reports published till date                   

Post-Purchase Benefit                                 

1hr of free analyst discussion                                 
10% off on customization

About Us:                                                                          

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services. 

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                               

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/vietnam-crawler-excavator-market-opportunities-assessment-forecast

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Vietnam Crawler Excavator Market to Reach 1,974 Units in Sales by 2029, Generating $94.5 Million in Revenue Over the Next 6 Years – Arizton

Tooiicy Fashion Officially Launches: Pre-Sales Now Live on Tooiicy.com

Tooiicy Fashion, the much-anticipated streetwear brand founded by entrepreneurial artist Juicecuzz from Dallas, Texas, has officially opened pre-sales on its website, www.tooiicy.com. Tooiicy Fashion is poised to reinvent casual streetwear for a new generation of trendsetters by known for fusing modern design with an effortlessly cool style.

Tooiicy Fashion is more than just clothing; it’s a lifestyle movement honoring uniqueness, self-expression, and Texas-rooted innovation from the creative vision of Juicecuzz, a rising star in the music and art sectors. With streetwear basics, T-shirts, and modern hoodies, Tooiicy hopes to improve daily wear by providing striking designs that mirror the urban society of today.

For this brand, “Elevate your style with Tooiicy” isn’t just a tagline—it’s a mission. Proudly crafted in Dallas, Texas, every piece from Tooiicy is designed with top-tier quality and authenticity in mind. The collection, soon to hit wardrobes nationwide, channels Juicecuzz’s artistic energy into garments that are stylish, comfortable, and made for those who dare to stand out.

“Tooiicy Fashion is about being unapologetically cool, bold, and chill all at once,” says Juicecuzz, founder and creative director. “We’re here to give people fashion that speaks their vibe—something unique and fresh that carries the essence of our city and culture.”

Behind the scenes, Tooiicy Fashion is backed by a well-prepared business strategy, robust financial projections, and a professional pitch deck, ensuring that this launch is more than just a moment—it’s a movement. Juicecuzz, who has already made a name for himself in the music world (available on Spotify, Apple Music, YouTube, and more), brings that same entrepreneurial spirit to the fashion industry.

The launch of Tooiicy is a calculated leap into the fashion market, with pre-sales marking the first opportunity for early supporters to grab exclusive pieces before the official drop.

To celebrate the brand’s debut, Tooiicy.com is now live for pre-orders, giving fans and fashion enthusiasts a first look at signature pieces like premium hoodies and contemporary T-shirts, all designed with Tooiicy’s distinctive style.

Customers eager to secure their favorite looks are encouraged to visit www.tooiicy.com and take advantage of limited-time pre-sale offers before the official release date.

For the latest updates, follow Tooiicy on Social Media.

Spotify: https://open.spotify.com/artist/4SvpQzLiyPUpxt6Ej7Iu9t

TikTok: https://www.tiktok.com/@juicecuzz?lang=en

Apple Music: https://music.apple.com/us/artist/juicecuzz/158487124

Media Contact
Company Name: Tooiicy Fashion
Contact Person: John
Email: Send Email
City: Dallas
State: Texas
Country: United States
Website: tooiicy.com

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Tooiicy Fashion Officially Launches: Pre-Sales Now Live on Tooiicy.com

Generalized Pustular Psoriasis Market Set for Significant Growth by 2034, Forecasts DelveInsight

The Generalized Pustular Psoriasis market is rapidly evolving, driven by ongoing research and emerging treatment advancements. DelveInsight’s latest 7MM report provides in-depth insights into key epidemiology trends and market dynamics.

DelveInsight’s “Generalized Pustular Psoriasis – Market Insight, Epidemiology, And Market Forecast – 2034″ report offers an in-depth understanding of the Generalized Pustular Psoriasis, historical and forecasted epidemiology as well as the Generalized Pustular Psoriasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.

Some of the key facts of the Generalized Pustular Psoriasis Market Report:

• According to DelveInsight, the market for Generalized Pustular Psoriasis in the 7MM is expected to experience notable growth during the forecast period from 2020 to 2034.

• Females are more likely to present with Generalized Pustular Psoriasis than males, according to the findings.

• In the US, the prevalent cases of Pustular Psoriasis were estimated to be approximately 240K in 2023.

• Generalized Pustular Psoriasis patients are often categorized into two groups: mild-to-moderate and moderate-to-severe psoriasis. In the US, the highest number of severity-specific cases in 2023 were found in the moderate-to-severe type.

• In March 2024, the US FDA expanded the approval for Boehringer’s SPEVIGO to include the treatment of Generalized Pustular Psoriasis in both adults and pediatric patients aged 12 and above (weighing ≥40 kg). Previously, it was approved for treatment only during acute flares in adults, and this expanded approval addresses both acute and chronic treatment needs for these patients.

• Additional treatments for Generalized Pustular Psoriasis include IL-36 pathway inhibitors, IL-17 inhibitors, IL-23 inhibitors, TNF-α inhibitors, retinoids, calcineurin inhibitors, anti-folate therapy, and PDE4 inhibitors.

• Emerging drugs in development for Generalized Pustular Psoriasis include TAK-279, Imsidolimab, JNJ-2113, and others.

• Key companies involved in the Generalized Pustular Psoriasis market include AnaptysBio, Takeda, Johnson & Johnson, and others.

• The growing need for both acute and chronic treatments, along with the ongoing development of novel therapies, is expected to significantly drive the market growth.

To Know in detail about the Generalized Pustular Psoriasis market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Generalized Pustular Psoriasis Market Forecast

Generalized Pustular Psoriasis Overview

Generalized Pustular Psoriasis (GPP) is a rare and severe form of psoriasis characterized by widespread sterile pustules on inflamed, erythematous skin. Unlike plaque psoriasis, GPP can present with systemic symptoms such as fever, chills, fatigue, and organ complications, making it a life-threatening condition if left untreated. The disease can occur in acute flare-ups or as a chronic condition with recurrent episodes.

The exact cause of GPP is not fully understood, but it is linked to genetic mutations, immune system dysregulation, and inflammatory cytokines, particularly interleukin-36 (IL-36). Triggers such as infections, stress, pregnancy, and withdrawal from corticosteroids can exacerbate the condition. Due to its severity and potential for complications like sepsis and multi-organ failure, early diagnosis and aggressive treatment are crucial.

Current treatment options for GPP include systemic therapies such as biologics (IL-36, IL-17, and IL-23 inhibitors), immunosuppressants, and supportive care for symptom management. With ongoing advancements in targeted therapies and increased awareness, the market for GPP treatment is expanding, improving patient outcomes and addressing the high unmet medical need.

Get a Free sample for the Generalized Pustular Psoriasis Market Report: https://www.delveinsight.com/report-store/generalized-pustular-psoriasis-market

Generalized Pustular Psoriasis Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Generalized Pustular Psoriasis Epidemiology Segmentation:

The Generalized Pustular Psoriasis epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:

• Total Prevalent Cases of Psoriasis in the 7MM

• Total Prevalent Cases of Pustular Psoriasis in the 7MM

• Total Prevalent Cases of Generalized Pustular Psoriasis in the 7MM

• Gender-specific Diagnosed Prevalent Cases of Generalized Pustular Psoriasis in the 7MM

• Age-specific Diagnosed Prevalent Cases of Generalized Pustular Psoriasis in the 7MM

• Severity-specific Diagnosed Prevalent Cases of Generalized Pustular Psoriasis in the 7MM

Download the report to understand which factors are driving Generalized Pustular Psoriasis epidemiology trends @ Generalized Pustular Psoriasis Epidemiology Forecast

Generalized Pustular Psoriasis Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Generalized Pustular Psoriasis market or expected to be launched during the study period. The analysis covers the Generalized Pustular Psoriasis market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Generalized Pustular Psoriasis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Generalized Pustular Psoriasis Market Strengths

• The development of novel biologics, particularly IL-36 inhibitors, is revolutionizing GPP treatment, offering more effective and personalized therapeutic options.

• Growing investments in research and a surge in clinical trials for innovative drugs are expanding treatment possibilities and driving market growth.

Generalized Pustular Psoriasis Market Weaknesses

• Due to its rarity, GPP is often misdiagnosed or underdiagnosed, leading to treatment delays and increased risk of complications.

• Advanced biologic therapies can be expensive, limiting access for patients in low-income regions and posing reimbursement challenges in some healthcare systems.

Scope of the Generalized Pustular Psoriasis Market Report

• Study Period: 2020–2034

• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

• Key Generalized Pustular Psoriasis Therapies: TAK-279, Imsidolimab, JNJ-2113, and others.

• Key Generalized Pustular Psoriasis Companies: AnaptysBio, Takeda, Johnson & Johnson, and others.

• Generalized Pustular Psoriasis Therapeutic Assessment: Generalized Pustular Psoriasis currently marketed and Generalized Pustular Psoriasis emerging therapies

• Generalized Pustular Psoriasis Market Dynamics: Generalized Pustular Psoriasis market drivers and Generalized Pustular Psoriasis market barriers

• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

• Generalized Pustular Psoriasis Unmet Needs, KOL’s views, Analyst’s views, Generalized Pustular Psoriasis Market Access and Reimbursement

To learn more about the key players and advancements in the Generalized Pustular Psoriasis Treatment Landscape, visit the Generalized Pustular Psoriasis Market Analysis Report

Table of Contents

1. Generalized Pustular Psoriasis Market Report Introduction

2. Executive Summary for Generalized Pustular Psoriasis

3. SWOT analysis of Generalized Pustular Psoriasis

4. Generalized Pustular Psoriasis Patient Share (%) Overview at a Glance

5. Generalized Pustular Psoriasis Market Overview at a Glance

6. Generalized Pustular Psoriasis Disease Background and Overview

7. Generalized Pustular Psoriasis Epidemiology and Patient Population

8. Country-Specific Patient Population of Generalized Pustular Psoriasis

9. Generalized Pustular Psoriasis Current Treatment and Medical Practices

10. Generalized Pustular Psoriasis Unmet Needs

11. Generalized Pustular Psoriasis Emerging Therapies

12. Generalized Pustular Psoriasis Market Outlook

13. Country-Wise Generalized Pustular Psoriasis Market Analysis (2020–2034)

14. Generalized Pustular Psoriasis Market Access and Reimbursement of Therapies

15. Generalized Pustular Psoriasis Market Drivers

16. Generalized Pustular Psoriasis Market Barriers

17. Generalized Pustular Psoriasis Appendix

18. Generalized Pustular Psoriasis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Generalized Pustular Psoriasis Market Set for Significant Growth by 2034, Forecasts DelveInsight

BPH Surgical Treatment Market worth $17.19 billion in 2030

“Prominent players in the BPH Surgical Treatment market drug type include GlaxoSmithKline PLC (UK), Eli Lilly and Company (US), Astellas Pharma Inc.(Japan), Viatris Inc. (US), Asahi Kasei Corporation (Japan), Organon & Co. (US), Alembic Pharmaceuticals Limited (India). And BPH Surgical Treatment type includes Teleflex Incorporated (US)”

Browse 368 market data Tables and 59 Figures spread through 328 Pages and in-depth TOC on “BPH Surgical Treatment Market by Type (TURP, Laser, Rezum, Urolift, Ablation, PAE), Drug Type (Alpha Blocker (Alfuzosin), Alpha Reductase Inhibitor (Dutastride), Therapy (Mono, Combination), End Users (Hospitals) – Global Forecast to 2030

The global Benign Prostatic Hyperplasia Surgical Treatment market, valued at US$11.92 billion in 2023, is forecasted to grow at a robust CAGR of 5.3%, reaching US$12.62 billion in 2024 and an impressive US$17.19 billion by 2030. Benign prostatic hyperplasia is a condition in males in which the prostate is enlarged, leading to difficulty in urinating. The growing incidence of benign prostatic hyperplasia (BPH) cases is expected to drive the demand for Benign Prostatic Hyperplasia Surgical Treatment. The aging population is a global demographic trend characterized by an increasing proportion of older individuals due to longer life expectancy and declining birth rates. The rising incidence of obesity in males is also expected to increase the incidence of BPH as the two factors are closely associated. Obesity leads to several issues, such as rising sympathetic nervous activity, altered endocrine status, increased intra-abdominal pressure, increased inflammation process, and oxidative stress, favorable conditions for developing BPH. However, the growing preference for minimally invasive surgeries is considered adequate, providing reduced recovery times and fewer complications compared to traditional surgery. Additionally, the high growth potential of emerging economies, along with the favorable funding investments for BPH drug development, are expected to provide lucrative growth opportunities for market players.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198000374

Browse in-depth TOC on “Benign Prostatic Hyperplasia Surgical Treatment Market“

368 – Tables

59 – Figures

328 – Pages

Based on drug type, the global Benign Prostatic Hyperplasia Surgical Treatment market can be divided into three segments: alpha-blockers (α-blockers), 5-alpha reductase inhibitors (5-ARIs), and other drug types [combination drugs, muscarinic receptor antagonists (MRAs), and phosphodiesterase 5 (PDE5) inhibitors]. The alpha-blockers (α-blockers) category is expected to have the highest CAGR from 2024 to 2030. Factors driving the growth of alpha-blockers (α-blockers), include an aging population. Alpha-blockers (α-blockers) are recommended as first-line treatment for BPH as it relax the smooth muscle of the prostate and bladder neck to improve urine flow and reduce bladder outlet obstruction. These are highly efficient drugs, such as monotherapy, in treating BPH-associated lower urinary tract symptoms (LUTS).

The Benign Prostatic Hyperplasia Surgical Treatment market, by type, is segmented into Transurethral Resection of the Prostate (TURP), Laser Surgery, UroLift Procedure, Rezūm Procedure, Robot-assisted Waterjet Ablation, Prostatic Stenting, Transurethral Microwave Thermotherapy (TUMT), Transurethral Needle Ablation of the Prostate (TUNA), Prostatic Arterial Embolization (PAE) and Other Procedures. The Transurethral Resection of the Prostate (TURP) segment is anticipated to witness the highest growth rate during the forecast period. This is because TURP, a well-established and cost-effective first-line preferred treatment procedure, is often covered by insurance and is typically less expensive than newer options regarding the procedure and hospital stay.

Based on therapy, the Benign Prostatic Hyperplasia Surgical Treatment market is segmented into monotherapy and combination drug therapy. In the upcoming years, monotherapy is expected to grow at the fastest rate because to the rising prevalence BPH patients, cost efficiency, and convenience in treating BPH. Low risk of side effects and drug interactions, significantly improving the quality of life.

Based on the type of end-user, the Benign Prostatic Hyperplasia Surgical Treatment market is divided into hospitals, ambulatory surgery centers & clinics, and home care setting. Between 2024 and 2030, the home care setting segment is predicted to expand at the fastest rate. The growth rate of the home care setting segment can be attributed to the large patient population of individuals being administered medication in the convenience and efficiency of indoor settings. Medications like alpha-blockers or 5-alpha reductase inhibitors can be taken orally, contributing to market growth.

The global Benign Prostatic Hyperplasia Surgical Treatment market has been segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC countries. The Asia Pacific region is expected to witness the highest growth rate during the forecast period.

North America is the largest regional market for BPH treatment. The North American market comprises the US and Canada. The rising geriatric and obese population and the availability of research funding are the major factors driving the market growth. Initiatives by key players are also expected to contribute to the market. The large share of the US in the North American BPH treatment market can be mainly attributed to the growing target population, the high incidence of BPH, and the strong presence of medical device manufacturers. Additionally, favorable reimbursement policies, high disposable incomes, a strong and improved healthcare infrastructure, research funding, and product launches.

The US has a strong healthcare system with advanced infrastructure. The robust healthcare infrastructure, combined with specialized healthcare facilities and a rising number of hospitals which drives the Benign Prostatic Hyperplasia Surgical Treatment market in the country. The growing geriatric population along with an increasing number of BPH cases is supporting the Benign Prostatic Hyperplasia Surgical Treatment market growth.

The funding supports the development of cutting—edge technologies like Robotic waterjet assistance which are increasingly shaping the BPH treatment landscape. For instance, Zenflow, Inc., a US-based medical device company that is developing a minimally invasive treatment for urinary obstruction caused by, benign prostatic hyperplasia announced that it has closed a USD 24 million Series C financing round. The round includes new investor Cook Medical as well as existing investors Indus Opportunities, F-Prime Capital, Medical Technology Venture Partners, and others.

Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=198000374

The Benign Prostatic Hyperplasia Surgical Treatment market is consolidated, with top companies holding significant market shares. The top three players in the drug type market include GlaxoSmithKline PLC (UK) Astellas Pharma Inc. (Japan) and Viatris Inc. (US. Also, the top three players in the type of market includes Teleflex Incorporated (US), Boston Scientific Corporation (US), and Olympus Corporation (Japan) dominating the market.

Players in this market are focusing on adopting organic and inorganic growth strategies such as product approvals, acquisitions, agreements, partnerships, and other developments such as regulatory approvals to increase their BPH treatment products portfolio, cater to customer needs, increase their profitability and expand their presence in the global Benign Prostatic Hyperplasia Surgical Treatment market.

By Drug Type

Viatris Inc. (US) is the leading player contributing a share of 10-12% in 2023 in the Benign Prostatic Hyperplasia Surgical Treatment Market The company offers 1,400 approved molecules of various therapeutic areas which includes key brands and generics recognized globally. The brand division caters to the BPH surgical products market, i.e., Apha1 adrenergic antagonist known as CARDURA (doxazosin).

GlaxoSmithKline PLC (UK) is the second leading Benign Prostatic Hyperplasia Surgical Treatment market player, with a 6.0-8.0% share in 2023. The Commercial Operations segment has three product groups: Vaccines, Specialty Medicines, and General Medicines. The company offers various products to treat chronic & acute diseases. The products for BHP treatment are provided through its General Medicines product group under the Commercial Operations segment. The company offers 5-Alpha-Reductase Inhibitors by the brand name Avodart and a combination drug with dutasteride 500 µg and 400 µg tamsulosin hydrochloride by the brand name Duodart. In July 2023, GlaxoSmithKline PLC and Recordati entered into an agreement with GSK to commercialize Avodart (dutasteride) and Combodart/Duodart (dutasteride/tamsulosin) across 21 countries, mainly in Europe, excluding only those where GSK already has a distribution agreement in place.

Astellas Pharma Inc. (Japan) In the Benign Prostatic Hyperplasia Surgical Treatment market the company accounts for a share of around 4-6% in 2023. Pharmaceutical products are manufactured and marketed by a single business segment. Th key segments targeted are immunology, anti-infectives, oncology, urology, and metabolic applications. The company provides alpha blocker Harnal (Tamsulosin hydrochloride) for the treatment BPH by the Urology category. The company have a global presence in around 40 countries across the world.

By Type

Boston Scientific Corporation (US) is the leading Benign Prostatic Hyperplasia Surgical Treatment market player, with a share of 9.0-10.0% in 2023. The various procedures offered by the company include Greenlight XPS Laser System, Moxy Fiber, and Rezum Systems for treating BPH.

Teleflex Incorporated (US) is ranked as the second leading player in the Benign Prostatic Hyperplasia Surgical Treatment market. In 2023, The company is contributing a share of 8.0-9.0% in 2023. The Interventional Urology segment offers the UroLift System which is a minimally invasive technology benign prostatic hyperplasia. The company has also introduced the UroLift system in China to make notable progress in advancing other high-growth products and line extensions through the regulatory process.

Olympus Corporation (Japan) accounted for a share of 8.0% in 2023 in the Benign Prostatic Hyperplasia Surgical Treatment market. The underlying high-frequency technology of PLASMA has been used for over 17 years. It offers proven therapy for patients with benign prostatic hyperplasia (BPH) and expanded reimbursement for differentiated MIS BPH devices, which provide better clinical outcomes and elevate the standard of care.

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023

We have selected six market vendors based on their capabilities, innovations, product offerings, and business strategies. A comprehensive list of all the vendors in this market was created through a product mapping strategy and MarketsandMarkets analysis. Our selected vendor mix includes companies from Tier 1–Tier 4 to cover the Benign Prostatic Hyperplasia Surgical Treatment market. Based on their performance in each criterion, the vendors are divided into four categories: Stars, Emerging Leaders, Omnipresent Players, and Participants.

For more information, Inquire Now!

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: BPH Surgical Treatment Market worth $17.19 billion in 2030